Cargando…
Pretreatment with inhaled procaterol improves symptoms of dyspnea and quality of life in patients with severe COPD
BACKGROUND: The clinical efficacy of short-acting β(2)-agonists administered before performing daily activities in chronic obstructive pulmonary disease (COPD) is unclear. The aim of this study was to investigate the clinical effect of supplementary inhaled procaterol hydrochloride in patients with...
Autores principales: | Ohbayashi, Hiroyuki, Adachi, Mitsuru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3396116/ https://www.ncbi.nlm.nih.gov/pubmed/22807639 http://dx.doi.org/10.2147/IJGM.S20833 |
Ejemplares similares
-
A Modified Method for Examining the Walking Pattern and Pace of COPD Patients in a 6-min Walk Test Before and After the Inhalation of Procaterol
por: Burioka, Naoto, et al.
Publicado: (2017) -
The effects of breathing exercises and inhaler training in patients with COPD on the severity of dyspnea and life quality: a randomized controlled trial
por: Ceyhan, Yasemin, et al.
Publicado: (2022) -
Effects of inhaled furosemide on dyspnea and pulmonary function in people with COPD: A literature review
por: Atwi, Zeina
Publicado: (2022) -
Exercise dyspnea in patients with COPD
por: Stendardi, Loredana, et al.
Publicado: (2007) -
Greater dyspnea is associated with lower health-related quality of life among European patients with COPD
por: Gruenberger, Jean-Bernard, et al.
Publicado: (2017)